KOTRA | KOTRA INDUSTRIES BHD

4.68 (0.43%)
4

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

KOTRA | KOTRA INDUSTRIES BHD


iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
21 Feb 24 Q2 Dec 23 2 30 Jun 24 57.55 11.88 11.62 20.2% 12.50 7.83 8.0% 7.6% 15.0% 29.2%
28 Nov 23 Q1 Sep 23 1 30 Jun 24 53.31 13.90 13.66 25.6% 0.00 9.21 4.5% 17.7% 4.4% 25.1%
23 Aug 23 Q4 Jun 23 4 30 Jun 23 55.80 13.49 13.09 23.5% 15.50 8.84 6.0% 14.4% 25.2% 19.4%
26 May 23 Q3 Mar 23 3 30 Jun 23 59.40 17.68 17.50 29.4% 0.00 11.82 4.6% 7.5% 6.6% 2.7%
24 Feb 23 Q2 Dec 22 2 30 Jun 23 62.25 16.55 16.41 26.4% 10.00 11.09 3.9% 17.9% 10.0% 18.0%
29 Nov 22 Q1 Sep 22 1 30 Jun 23 64.75 18.35 18.24 28.2% 0.00 12.33 32.8% 26.7% 12.3% 22.3%
29 Aug 22 Q4 Jun 22 4 30 Jun 22 48.77 12.35 16.24 33.3% 0.00 10.97 11.7% 12.2% 4.7% 30.5%
30 May 22 Q3 Mar 22 3 30 Jun 22 55.24 17.09 17.04 30.8% 0.00 11.51 4.6% 27.5% 22.5% 172.8%
24 Feb 22 Q2 Dec 21 2 30 Jun 22 52.82 13.91 13.90 26.3% 9.50 9.40 3.4% 38.3% 6.8% 331.0%
26 Nov 21 Q1 Sep 21 1 30 Jun 22 51.09 14.92 14.92 29.2% 0.00 10.08 17.5% 47.5% 19.9% 501.8%
02 Sep 21 Q4 Jun 21 4 30 Jun 21 43.48 14.30 12.44 28.6% 0.00 8.43 0.3% 18.3% 99.2% 57.4%
28 May 21 Q3 Mar 21 3 30 Jun 21 43.34 6.24 6.25 14.4% 0.00 4.23 13.5% 6.8% 93.6% 18.0%
19 Feb 21 Q2 Dec 20 2 30 Jun 21 38.18 3.23 3.23 8.4% 0.02 2.19 10.3% 21.9% 30.1% 63.8%
20 Nov 20 Q1 Sep 20 1 30 Jun 21 34.63 2.49 2.48 7.2% 0.00 1.68 5.8% 12.5% 68.6% 51.7%
14 Aug 20 Q4 Jun 20 4 30 Jun 20 36.76 4.17 7.91 21.5% 0.00 5.46 20.9% 7.6% 3.8% 21.1%
22 May 20 Q3 Mar 20 3 30 Jun 20 46.51 7.63 7.62 16.4% 0.00 5.26 4.9% 14.2% 14.4% 47.4%
05 Feb 20 Q2 Dec 19 2 30 Jun 20 48.89 8.94 8.90 18.2% 0.04 6.36 23.6% 8.6% 73.3% 84.2%
28 Nov 19 Q1 Sep 19 1 30 Jun 20 39.57 5.18 5.14 13.0% 0.00 3.68 0.6% 15.8% 21.3% 9.5%
22 Aug 19 Q4 Jun 19 4 30 Jun 19 39.80 5.58 6.53 16.4% 0.00 4.68 2.3% 10.2% 26.3% 17.1%
17 May 19 Q3 Mar 19 3 30 Jun 19 40.73 5.21 5.17 12.7% 0.00 3.71 9.5% 8.6% 7.0% 40.9%
19 Feb 19 Q2 Dec 18 2 30 Jun 19 45.01 4.88 4.83 10.7% 0.03 3.47 4.3% 3.1% 14.9% 14.8%
22 Nov 18 Q1 Sep 18 1 30 Jun 19 47.01 5.70 5.67 12.1% 0.00 4.25 6.1% 8.9% 1.8% 146.5%
21 Aug 18 Q4 Jun 18 4 30 Jun 18 44.30 5.65 5.57 12.6% 0.00 4.19 0.6% 5.0% 52.0% 188.7%
14 May 18 Q3 Mar 18 3 30 Jun 18 44.56 3.70 3.67 8.2% 0.00 2.76 4.0% 1.5% 12.9% 20.0%
13 Feb 18 Q2 Dec 17 2 30 Jun 18 46.44 4.25 4.21 9.1% 0.02 3.17 7.6% 3.0% 82.9% 26.8%
23 Nov 17 Q1 Sep 17 1 30 Jun 18 43.18 2.30 2.30 5.3% 0.00 1.73 2.4% 27.4% 19.2% 1670.0%
23 Aug 17 Q4 Jun 17 4 30 Jun 17 42.18 2.06 1.93 4.6% 0.00 1.46 6.7% 3.2% 57.9% 32.5%
19 May 17 Q3 Mar 17 3 30 Jun 17 45.22 4.58 4.58 10.1% 0.00 3.46 0.3% 7.0% 20.3% 578.1%
08 Feb 17 Q2 Dec 16 2 30 Jun 17 45.07 5.75 5.75 12.8% 0.02 4.34 33.0% 14.6% 4324.6% 873.3%
23 Nov 16 Q1 Sep 16 1 30 Jun 17 33.89 0.13 0.13 0.4% 0.00 0.10 17.0% 10.3% 95.5% 96.4%
29 Aug 16 Q4 Jun 16 4 30 Jun 16 40.85 2.97 2.86 7.0% 0.00 2.17 3.3% 6.9% 323.4% 268.8%
25 May 16 Q3 Mar 16 3 30 Jun 16 42.26 0.68 0.68 1.6% 0.00 0.51 7.4% 19.4% 14.4% 8.7%
25 Feb 16 Q2 Dec 15 2 30 Jun 16 39.34 0.59 0.59 1.5% 0.00 0.45 4.1% 0.1% 83.7% 74.4%
26 Nov 15 Q1 Sep 15 1 30 Jun 16 37.78 3.63 3.63 9.6% 0.00 2.74 1.1% 17.4% 368.0% 231.6%
27 Aug 15 Q4 Jun 15 4 30 Jun 15 38.22 0.89 0.78 2.0% 0.00 0.59 8.0% 10.7% 4.9% 78.2%
27 May 15 Q3 Mar 15 3 30 Jun 15 35.40 0.74 0.74 2.1% 0.00 0.56 10.1% 18.1% 67.9% 86.5%
16 Feb 15 31/12/14 2 30/06/15 39.39 2.31 2.31 5.8% 0.00 1.74 22.4% 11.0% 183.5% 13458.8%

Historical Dividends

Financial Ratios

EPS 37.66 sen
Trailing PE (Sector Median: 16.9) 12.4
PEG 12.4
Altman Z 2.5
Beaver 0.722
Current Ratio 3.46
Debt-Equity (DE) Ratio 0.19
FCF Yield 3.32 %
Revenue QoQ 7.95 %
Revenue YoY -7.56%
Profit QoQ -14.96 %
Profit YoY -29.22 %
Profit Margin (Sector Median: 7.9) 24.71 %
ROE (ROIC: 20.34) 20.34 %
Dividend Per Share (DPS) 28.0 sen
Dividend Yield (DY) 5.98 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 16.9)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 7.9)
ROE (ROIC: 19.37)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 3 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 1.85
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 11.62
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 56.97
Expected Revenue (M) 438.53
Expected Growth (%) 20.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Summary


Market Cap: 694 M.

Number of Shares: 148 M.

Adjusted Float: 56.4%.

Stock highly correlated with

MUDAJYA (87%)

KSSC (84%)

MHB (84%)

EIB (83%)

Kotra Industries Berhad, an investment holding company is engaged in developing, manufacturing and trading pharmaceutical and healthcare products in Malaysia and other countries in the Asia Pacific. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd. It offers pharmaceutical products in various dosage forms, which include tablets, capsules, cream/ointment/gel, liquid, dry powder preparations and injectables. The company manufactures over-the-counter (OTC) products that include dietary supplements for infants and teenagers, multivitamin tablets and syrups for kids, vitamin and mineral supplements for pregnant and lactating women, antioxidant vitamins for adults, products for weight gain-related conditions, and wellness products for seniors. It also offers over-the-counter and prescription products, such as peripheral vasolidators, antacid and gastric ulcer remedies, antifungals, dermatologicals, anthelmentics, cough preparations, analgesics and antipyretics, mouth and throat preparations, and antirheumatics. The company's prescription products also include antihistamines/antiemetics, cold preparations, anti-asthmatics, anti-diarrhoeals, antibiotics, antivirals, corticosteroids, anaesthetics, vitamins and minerals, anti-inflammatory products, antispasmodics, antimalarials, anticoagulants and hormones and gynaecological products including Predicates ovulation test kits and Thames sperm enhancer kits. It offers OTC health supplements under Appeton brand, nutriceutical beverages under the Booster brand, anti-fungal Creobic Cream and a range of prescriptive products under Axcel and Vaxcel brand names. The company was incorporated in 1985 and is based in Melaka, Malaysia.

Sectors: Consumer Products, Healthcare, Pharmaceuticals

Code: 0002

Website: http://www.kotrapharma.com

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 29-Sep-2023

Shareholder % Value (M)
Piong Nam Kim Holdings Sdn Bhd 43.57% 302.42
Piong Teck Onn 12.34% 85.65
Piong Teck Yen 3.92% 27.21
Piong Teck Min 3.38% 23.46
Piong Chee Wei 2.55% 17.7
Platinum Essence Sdn. Bhd. 1.89% 13.12
Kok Hon Seng 1.69% 11.73
Cheah Chang Han 1.65% 11.45
Chin Swee Chang 1.56% 10.83
Ji Yeh Ming 1.35% 9.37
Seah Tin Kim 1.24% 8.61
Medisch Specialist Centre Sdn Bhd 1.12% 7.77
Lim Kian Tiak 1.01% 7.01
Ho Jonathan Lep Kee 0.82% 5.69
Fong Siling 0.81% 5.62
Cheah Ming Loong 0.78% 5.41
Ooi Lee Peng 0.61% 4.23
Piong Tech Fong 0.53% 3.68
Triple Boutique Sdn Bhd 0.52% 3.61
Piong Teck Wah 0.52% 3.61
Sin Boon Fei 0.42% 2.92
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.